guidelines:
  1: IMDC_risk_model_metastiatic_renal_cell_carcinoma.v1
test_cases:
- id: Default
  input:
    1: {}
  expected_output:
    1:
      gt0010|Karnofsky Performance Status <80%: 0|local::at0010|No +0|
      gt0014|Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL: 0|local::at0012|No +0|
      gt0016|Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L: 0|local::at0016|No +0|
      gt0026|Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL: 0|local::at0018|No +0|

- id: IMDC Risk Score = 6
  input:
    1:
      gt0003|Haemoglobin: 100,gm/l
      gt0004|Platelet count: 450000,cells/uL
      gt0005|Neutrophils: 8,10*9/l
      gt0007|Karnofsky score: 70
      gt0023|<1 year from time of diagnosis to systemic therapy: 1|local::at0009|Yes +1|
      gt0024|Corrected calcium > upper limit of normal. Usually ~8.5-10.2 mg/dL: 1|local::at0015|Yes +1|
  expected_output:
    1:
      gt0013|IMDC Risk Score: 6
      gt0011|Median survival: local::at0024|7.8 months|
      gt0010|Karnofsky Performance Status <80%: 1|local::at0011|Yes +1|
      gt0012|Risk Group: local::at0028|Poor|
      gt0014|Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL: 1|local::at0013|Yes +1|
      gt0016|Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L: 1|local::at0017|Yes +1|
      gt0026|Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL: 1|local::at0019|Yes +1|

- id: IMDC Risk Score = 5
  input:
    1:
      gt0003|Haemoglobin: 100,gm/l
      gt0004|Platelet count: 450000,cells/uL
      gt0005|Neutrophils: 6,10*9/l
      gt0007|Karnofsky score: 70
      gt0023|<1 year from time of diagnosis to systemic therapy: 1|local::at0009|Yes +1|
      gt0024|Corrected calcium > upper limit of normal. Usually ~8.5-10.2 mg/dL: 1|local::at0015|Yes +1|
  expected_output:
    1:
      gt0013|IMDC Risk Score: 5
      gt0011|Median survival: local::at0024|7.8 months|
      gt0010|Karnofsky Performance Status <80%: 1|local::at0011|Yes +1|
      gt0012|Risk Group: local::at0028|Poor|
      gt0014|Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL: 1|local::at0013|Yes +1|
      gt0016|Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L: 0|local::at0016|No +0|
      gt0026|Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL: 1|local::at0019|Yes +1|

- id: IMDC Risk Score = 4
  input:
    1:
      gt0003|Haemoglobin: 100,gm/l
      gt0004|Platelet count: 450000,cells/uL
      gt0005|Neutrophils: 6,10*9/l
      gt0007|Karnofsky score: 90
      gt0023|<1 year from time of diagnosis to systemic therapy: 1|local::at0009|Yes +1|
      gt0024|Corrected calcium > upper limit of normal. Usually ~8.5-10.2 mg/dL: 1|local::at0015|Yes +1|
  expected_output:
    1:
      gt0013|IMDC Risk Score: 4
      gt0011|Median survival: local::at0024|7.8 months|
      gt0010|Karnofsky Performance Status <80%: 0|local::at0010|No +0|
      gt0012|Risk Group: local::at0028|Poor|
      gt0014|Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL: 1|local::at0013|Yes +1|
      gt0016|Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L: 0|local::at0016|No +0|
      gt0026|Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL: 1|local::at0019|Yes +1|

- id: IMDC Risk Score = 3
  input:
    1:
      gt0003|Haemoglobin: 100,gm/l
      gt0004|Platelet count: 350000,cells/uL
      gt0005|Neutrophils: 6,10*9/l
      gt0007|Karnofsky score: 90
      gt0023|<1 year from time of diagnosis to systemic therapy: 1|local::at0009|Yes +1|
      gt0024|Corrected calcium > upper limit of normal. Usually ~8.5-10.2 mg/dL: 1|local::at0015|Yes +1|
  expected_output:
    1:
      gt0013|IMDC Risk Score: 3
      gt0011|Median survival: local::at0024|7.8 months|
      gt0010|Karnofsky Performance Status <80%: 0|local::at0010|No +0|
      gt0012|Risk Group: local::at0028|Poor|
      gt0014|Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL: 1|local::at0013|Yes +1|
      gt0016|Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L: 0|local::at0016|No +0|
      gt0026|Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL: 0|local::at0018|No +0|

- id: IMDC Risk Score = 2
  input:
    1:
      gt0003|Haemoglobin: 130,gm/l
      gt0004|Platelet count: 350000,cells/uL
      gt0005|Neutrophils: 6,10*9/l
      gt0007|Karnofsky score: 90
      gt0023|<1 year from time of diagnosis to systemic therapy: 1|local::at0009|Yes +1|
      gt0024|Corrected calcium > upper limit of normal. Usually ~8.5-10.2 mg/dL: 1|local::at0015|Yes +1|
  expected_output:
    1:
      gt0013|IMDC Risk Score: 2
      gt0011|Median survival: local::at0023|22.5 months|
      gt0010|Karnofsky Performance Status <80%: 0|local::at0010|No +0|
      gt0012|Risk Group: local::at0027|Intermediate|
      gt0014|Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL: 0|local::at0012|No +0|
      gt0016|Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L: 0|local::at0016|No +0|
      gt0026|Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL: 0|local::at0018|No +0|

- id: IMDC Risk Score = 1
  input:
    1:
      gt0003|Haemoglobin: 130,gm/l
      gt0004|Platelet count: 350000,cells/uL
      gt0005|Neutrophils: 6,10*9/l
      gt0007|Karnofsky score: 90
      gt0023|<1 year from time of diagnosis to systemic therapy: 0|local::at0008|No +0|
      gt0024|Corrected calcium > upper limit of normal. Usually ~8.5-10.2 mg/dL: 1|local::at0015|Yes +1|
  expected_output:
    1:
      gt0013|IMDC Risk Score: 1
      gt0011|Median survival: local::at0023|22.5 months|
      gt0010|Karnofsky Performance Status <80%: 0|local::at0010|No +0|
      gt0012|Risk Group: local::at0027|Intermediate|
      gt0014|Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL: 0|local::at0012|No +0|
      gt0016|Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L: 0|local::at0016|No +0|
      gt0026|Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL: 0|local::at0018|No +0|

- id: IMDC Risk Score = 0
  input:
    1:
      gt0003|Haemoglobin: 130,gm/l
      gt0004|Platelet count: 350000,cells/uL
      gt0005|Neutrophils: 6,10*9/l
      gt0007|Karnofsky score: 90
      gt0023|<1 year from time of diagnosis to systemic therapy: 0|local::at0008|No +0|
      gt0024|Corrected calcium > upper limit of normal. Usually ~8.5-10.2 mg/dL: 0|local::at0014|No +0|
  expected_output:
    1:
      gt0013|IMDC Risk Score: 0
      gt0011|Median survival: local::at0022|43.2 months|
      gt0010|Karnofsky Performance Status <80%: 0|local::at0010|No +0|
      gt0012|Risk Group: local::at0026|Favorable|
      gt0014|Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL: 0|local::at0012|No +0|
      gt0016|Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L: 0|local::at0016|No +0|
      gt0026|Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL: 0|local::at0018|No +0|
